Importer of Controlled Substances Application: Groff NA Hemplex LLC, 101051-101052 [2024-29343]

Download as PDF 101051 Federal Register / Vol. 89, No. 240 / Friday, December 13, 2024 / Notices hearing on October 3, 2024. All persons who requested the opportunity were permitted to participate. The Commission made these determinations pursuant to section 751(c) of the Act (19 U.S.C. 1675(c)). It completed and filed its determinations in these reviews on December 10, 2024. The views of the Commission are contained in USITC Publication 5565 (December 2024), entitled Steel Concrete Reinforcing Bar from Belarus, China, Indonesia, Latvia, Moldova, Poland, Ukraine: Investigation Nos. 731–TA–873–875, 878–880, and 882 (Fourth Review). individuals must contact the office listed above by 5 p.m. (eastern time) on December 31, 2024. After this deadline, only remote observation is permitted. Remote registration is available until the meeting date, provided it is completed before the projected end time. The announcement for this hearing was previously published in the Federal Register on October 28, 2024 at 89 FR 85557. (Authority: 28 U.S.C. 2073.) Controlled substance Dated: December 9, 2024. Shelly L. Cox, Management Analyst, Rules Committee Staff. [FR Doc. 2024–29330 Filed 12–12–24; 8:45 am] By order of the Commission. Issued: December 10, 2024. Lisa Barton, Secretary to the Commission. BILLING CODE 2210–55–P DEPARTMENT OF JUSTICE [FR Doc. 2024–29441 Filed 12–12–24; 8:45 am] Drug Enforcement Administration BILLING CODE 7020–02–P [Docket No. DEA–1459] JUDICIAL CONFERENCE OF THE UNITED STATES Bulk Manufacturer of Controlled Substances Application: National Center for Natural Products Research Committee on Rules of Practice and Procedure; Meeting of the Judicial Conference Judicial Conference of the United States. ACTION: Committee on Rules of Practice and Procedure; revised notice of open meeting. The Committee on Rules of Practice and Procedure will hold a meeting in a hybrid format with remote attendance options on January 7, 2025 in San Diego, CA as previously announced. The meeting is open to the public for observation but not participation. Please see the Supplementary Information section in this notice for instructions on observing the meeting. DATES: January 7, 2025 (meeting date) and December 31, 2024 (registration deadline for in person observation). ADDRESSES: An agenda and supporting materials will be posted at least 7 days in advance of the meeting at: https:// www.uscourts.gov/rules-policies/ records-and-archives-rules-committees/ agenda-books. FOR FURTHER INFORMATION CONTACT: H. Thomas Byron III, Esq., Chief Counsel, Rules Committee Staff, Administrative Office of the U.S. Courts, Thurgood Marshall Federal Judiciary Building, One Columbus Circle NE, Suite 7–300, Washington, DC 20544, Phone (202) 502–1820, RulesCommittee_Secretary@ ao.uscourts.gov. SUPPLEMENTARY INFORMATION: To observe the meeting in person, khammond on DSK9W7S144PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:17 Dec 12, 2024 Jkt 265001 Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: AGENCY: National Center for Natural Products Research has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before February 11, 2025. Such persons may also file a written request for a hearing on the application on or before February 11, 2025. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. SUMMARY: PO 00000 Frm 00103 Fmt 4703 Sfmt 4703 In accordance with 21 CFR 1301.33(a), this is notice that on September 5, 2024, National Center for Natural Products Research, Coy Waller Research Center, 806 Hathorn Road, University, Mississippi 38677–1848 applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: Marihuana Extract ......... Marihuana ...................... Tetrahydrocannabinols .. Drug code 7350 7360 7370 Schedule I I I The company plans to manufacture the listed controlled substances for product development and reference standards. In reference to drug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to isolate these controlled substances from procured 7350 (Marihuana Extract). In reference to drug code 7360, no cultivation activities are authorized for this registration. No other activities for these drug codes are authorized for this registration. Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2024–29341 Filed 12–12–24; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–1451] Importer of Controlled Substances Application: Groff NA Hemplex LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Groff NA Hemplex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before January 13, 2025. Such persons may also file a written request for a hearing on the application on or before January 13, 2025. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, SUMMARY: E:\FR\FM\13DEN1.SGM 13DEN1 101052 Federal Register / Vol. 89, No. 240 / Friday, December 13, 2024 / Notices which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. In accordance with 21 CFR 1301.34(a), this is notice that on September 30, 2024, Groff NA Hemplex LLC, 2218 South Queen Street, York, Pennsylvania 17402, applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: Controlled substance khammond on DSK9W7S144PROD with NOTICES Marihuana Extract ......... Marihuana ...................... Tetrahydrocannabinols .. Drug code 7350 7360 7370 Schedule I I I The company plans to import the listed controlled substances in bulk form to manufacture research grade material for clinical trial studies. Several types of Marihuana Extract compounds are listed under drug code 7350. No other activities for these drug codes are authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2024–29343 Filed 12–12–24; 8:45 am] BILLING CODE P VerDate Sep<11>2014 18:17 Dec 12, 2024 Jkt 265001 DEPARTMENT OF LABOR Agency Information Collection Activities; Submission for OMB Review; Comment Request; Reports of Injuries to Employees Operating Mechanical Power Presses Notice of availability; request for comments. ACTION: The Department of Labor (DOL) is submitting this Occupational Safety & Health Administration (OSHA)sponsored information collection request (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (PRA). Public comments on the ICR are invited. DATES: The OMB will consider all written comments that the agency receives on or before January 13, 2025. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. FOR FURTHER INFORMATION CONTACT: Nicole Bouchet by telephone at 202– 693–0213, or by email at DOL_PRA_ PUBLIC@dol.gov. SUPPLEMENTARY INFORMATION: In the event an employee is injured while operating a mechanical power press, 29 CFR 1910.217(g) requires an employer to provide information to OSHA regarding the accident. This information includes the employer’s and employee’s name, the type of clutch, the type of safeguard(s) used, the cause of the accident, the means to actuate the press stroke, and the number of operators involved. For additional substantive information about this ICR, see the related notice published in the Federal Register on June 7, 2024 (89 FR 48691). Comments are invited on: (1) whether the collection of information is necessary for the proper performance of the functions of the Department, including whether the information will have practical utility; (2) the accuracy of the agency’s estimates of the burden and cost of the collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility and clarity of the information collection; and (4) ways to minimize the burden of the collection of information on those who are to respond, including the use of SUMMARY: PO 00000 Frm 00104 Fmt 4703 Sfmt 4703 automated collection techniques or other forms of information technology. This information collection is subject to the PRA. A Federal agency generally cannot conduct or sponsor a collection of information, and the public is generally not required to respond to an information collection, unless the OMB approves it and displays a currently valid OMB Control Number. In addition, notwithstanding any other provisions of law, no person shall generally be subject to penalty for failing to comply with a collection of information that does not display a valid OMB Control Number. See 5 CFR 1320.5(a) and 1320.6. DOL seeks PRA authorization for this information collection for three (3) years. OMB authorization for an ICR cannot be for more than three (3) years without renewal. The DOL notes that information collection requirements submitted to the OMB for existing ICRs receive a month-to-month extension while they undergo review. Agency: DOL–OSHA. Title of Collection: Reports of Injuries to Employees Operating Mechanical Power Presses. OMB Control Number: 1218–0070. Affected Public: Private Sector— Businesses or other for-profits. Total Estimated Number of Respondents: 960. Total Estimated Number of Responses: 1,920. Total Estimated Annual Time Burden: 320 hours. Total Estimated Annual Other Costs Burden: $0. (Authority: 44 U.S.C. 3507(a)(1)(D)) Nicole Bouchet, Senior Paperwork Reduction Act Analyst. [FR Doc. 2024–29339 Filed 12–12–24; 8:45 am] BILLING CODE 4510–26–P NATIONAL CREDIT UNION ADMINISTRATION Revision of Agency Information Collection of a Previously Approved Collection; Request for Comments National Credit Union Administration (NCUA). ACTION: Notice of submission to the Office of Management and Budget. AGENCY: As required by the Paperwork Reduction Act of 1995, The National Credit Union Administration (NCUA) is submitting the following extensions and revisions of currently approved collections to the Office of Management and Budget (OMB) for renewal. DATES: Written comments should be received on or before January 13, 2025 to be assured consideration. SUMMARY: E:\FR\FM\13DEN1.SGM 13DEN1

Agencies

[Federal Register Volume 89, Number 240 (Friday, December 13, 2024)]
[Notices]
[Pages 101051-101052]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-29343]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1451]


Importer of Controlled Substances Application: Groff NA Hemplex 
LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Groff NA Hemplex LLC has applied to be registered as an 
importer of basic class(es) of controlled substance(s). Refer to 
Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants, therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
January 13, 2025. Such persons may also file a written request for a 
hearing on the application on or before January 13, 2025.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal,

[[Page 101052]]

which provides the ability to type short comments directly into the 
comment field on the web page or attach a file for lengthier comments. 
Please go to https://www.regulations.gov and follow the online 
instructions at that site for submitting comments. Upon submission of 
your comment, you will receive a Comment Tracking Number. Please be 
aware that submitted comments are not instantaneously available for 
public view on https://www.regulations.gov. If you have received a 
Comment Tracking Number, your comment has been successfully submitted 
and there is no need to resubmit the same comment. All requests for a 
hearing must be sent to: (1) Drug Enforcement Administration, Attn: 
Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 
22152; and (2) Drug Enforcement Administration, Attn: DEA Federal 
Register Representative/DPW, 8701 Morrissette Drive, Springfield, 
Virginia 22152. All requests for a hearing should also be sent to: Drug 
Enforcement Administration, Attn: Administrator, 8701 Morrissette 
Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on September 30, 2024, Groff NA Hemplex LLC, 2218 South 
Queen Street, York, Pennsylvania 17402, applied to be registered as an 
importer of the following basic class(es) of controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Marihuana Extract......................     7350  I
Marihuana..............................     7360  I
Tetrahydrocannabinols..................     7370  I
------------------------------------------------------------------------

    The company plans to import the listed controlled substances in 
bulk form to manufacture research grade material for clinical trial 
studies. Several types of Marihuana Extract compounds are listed under 
drug code 7350. No other activities for these drug codes are authorized 
for this registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-approved finished 
dosage forms for commercial sale.

Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024-29343 Filed 12-12-24; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.